Sen, F. Et Al. 2016. Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy. MEDICINE , vol.95, no.30 .

Sen, F., Tambas, M., Ozkaya, K., Guveli, M. E., Ciftci, R., Ozkan, B., ... Oral, E. N.(2016). Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy. MEDICINE , vol.95, no.30.

Sen, Fatma Et Al. "Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy," MEDICINE , vol.95, no.30, 2016

Sen, Fatma Et Al. "Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy." MEDICINE , vol.95, no.30, 2016

Sen, F. Et Al. (2016) . "Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy." MEDICINE , vol.95, no.30.

@article{article, author={Fatma Sen Et Al. }, title={Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy}, journal={MEDICINE}, year=2016}